Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 10Lymphoma 5Neoplasms, Germ Cell and Embryonal 3Seminoma 2Vulvar Neoplasms 1Testicular Neoplasms 1Teratoma 1Neoplasms, Second Primary 1Neoplasms 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Hemangioma, Capillary 1Endodermal Sinus Tumor 1Desmoid Tumors 1Carcinoma, Embryonal 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Etoposide 2Carboplatin 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Standard of Care 1Second-Look Surgery 1Respiratory Physiological Phenomena 1Reoperation 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cisplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Embryonal × Bleomycin × 1 year × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡